Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2003
10/15/2003EP1351961A1 Substituted indolines as 5-ht receptor ligands
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351937A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351935A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351932A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP1351742A2 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
10/15/2003EP1351707A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/15/2003EP1351692A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor
10/15/2003EP1351688A1 Urotensin-ii receptor antagonists
10/15/2003EP1351687A2 Urotensin-ii receptor antagonists
10/15/2003EP1351683A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2003EP1351682A1 Regulation of lipids and/or bone density and compositions therefor
10/15/2003EP1351679A2 Method and composition for the treatment of diabetic neuropathy
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1206457B1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP1007096B1 Arginine silicate inositol complex and use thereof
10/15/2003EP0998464B1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
10/15/2003EP0972768B1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same
10/15/2003EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449404A Amine salt of lignan compound
10/15/2003CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449381A New compounds having activity of lowing blood fat and cholesterol, their preparation method and pharmaceutical compositions containing them
10/15/2003CN1449377A Inhibitors of alpha4 mediated cell adhesion
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1449284A 维生素c组合物 Vitamin c composition
10/15/2003CN1448498A Health preserving wine and its making method
10/15/2003CN1448171A Blood sugar and glucose in urine lowering capsule
10/15/2003CN1448151A Hypoglycemic liquid and its prep.
10/15/2003CN1448143A Prescription composition of calcium carbonate dry-mixing suspension agent
10/15/2003CN1448075A Prep. of manganese-enriched nutrient extender
10/15/2003CN1448062A Xiaokezhi health tea
10/15/2003CN1124282C Conformationally constrained backbone cyclized somatostatin analogs
10/15/2003CN1124260C Para retinoic acid
10/15/2003CN1124254C Process for preparing optical-purity fluoxetine
10/15/2003CN1124140C Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes
10/15/2003CN1124134C Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preven
10/15/2003CN1124133C Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and pre
10/15/2003CN1124130C Pharmaceutical preparation comprising colodronate as active ingredient and silicified microcrystalline cellulose as excipient
10/15/2003CN1124084C Ultrahigh cellulose weight-reducing food
10/15/2003CN1124082C Green food able to regulate human cytometaplasia gene
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632838 Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
10/14/2003US6632801 Method and composition for inhibiting human cholesterol esterase
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632460 Treating angina pectoris, reducing the usage of nitroglycerin
10/14/2003US6632454 Multilayer pharmaceutical product for release in the colon
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2271865C Tablet composition
10/09/2003WO2003083442A2 Life sciences business systems and methods
10/09/2003WO2003083064A2 Chimeric pancreas
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082898A2 Novel analogues of glucose-dependent insulinotropic polypeptide
10/09/2003WO2003082878A1 Substituted amino isoxazoline derivatives and their use as anti-depressants.
10/09/2003WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082859A1 Indolylmaleimide derivatives
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082817A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003WO2003082816A1 New atorvastatin salts and pharmaceutical compositions containing them
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082802A1 Acid and ester compounds and methods of using the same
10/09/2003WO2003082800A1 Compounds that stimulate glucose utilization and methods of use
10/09/2003WO2003082798A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082335A1 Novel blood sugar controller and method of screening the same
10/09/2003WO2003082313A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003WO2003082300A1 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082276A1 Antidiabetic agents
10/09/2003WO2003082274A1 Angiogenesis inhibitors
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2003082269A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003WO2003082259A1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases
10/09/2003WO2003082240A1 Preparation containing fatty acid, used for reducing appetite, satiating, and/or reducing weight
1 ... 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 ... 1298